Advertisement RTI Biologics signs distribution and supply agreement with Aesculap - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RTI Biologics signs distribution and supply agreement with Aesculap

RTI Biologics, a provider of sterile biological implants, has signed an agreement to provide spinal allograft implants to Aesculap Implant Systems, a provider of spine and orthopedic products.

Under the agreement, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems.

Brian Hutchison, chairman and CEO of RTI, said: “We are pleased to work with Aesculap Implant Systems to deliver more sterilized spinal implants to surgeons. Through our agreement, we will be able to help even more patients with biologic solutions in spinal surgeries.”